This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
Disease trajectory and relapse
MM disease trajectory characterized by malignant transformationa
Reproduced with permission of Harborside Press. From Kurtin SE. Relapsed or relapsed/refractory multiple
myeloma. J Adv Pract Oncol. 2013;4(suppl 1):5-14; permission conveyed through Copyright Clearance Center, Inc.1
aVariable timeline dependent on individual risk factors, including genetic and phenotypic changes, depth and duration of response to therapy, persistence of a malignant MM stem cell, and evolution of competing MM clones.
MM, multiple myeloma
Kurtin SE. J Adv Pract Oncol. 2013;4(suppl 1):5-14.
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.